; and (ii) prioritize such specification of accrediting organizations that are widely recognized by both public and private entities as having experience in the accreditation of such facilities. (B) Facility requirements The requirements described in this subparagraph are, with respect to a facility and electrodiagnostic services furnished at such facility, the following: (i) The facility establishes and maintains a quality assurance and control program to ensure the reliability, safety, and accuracy of such service. (ii) The facility ensures that such service is conducted using a device capable of performing both nerve conduction studies that record amplitude and latency and needle electromyography tests capable of real-time waveform display and analysis. (iii) In the case that such service is a needle electromyography test, the facility ensures that the individual furnishing such test has completed not less than 3 months of training in performing and interpreting electrodiagnostic studies during a residency or fellowship program accredited by the Accreditation Council for Graduate Medical Education or the Royal College of Physicians and Surgeons of Canada, or by an individual described in section 410.32(b)(2)(iv) of title 42, Code of Federal Regulations (or a successor regulation). (iv) The facility ensures that the results are interpreted on-site and at the time of the procedure— (I) in the case of a needle electromyography test, by the individual who performed such test; and (II) in the case of a nerve conduction study, by the individual who performed or supervised such study. (v) Any other requirement determined appropriate by the Secretary. (C) Regulations Not later than 1 year after the date of the enactment of this subsection, the Secretary shall finalize regulations that outline— (i) the process by which an accrediting organization may be specified under subparagraph (A)